United States:
CMS Delays Enforcement Of Medicare Part D Prescriber Enrollment Requirement Until February 1, 2017
To print this article, all you need is to be registered or login on Mondaq.com.
CMS is delaying until February 1, 2017 enforcement of previously-adopted regulations that require
physicians and other eligible professionals who prescribe Part D
drugs to be enrolled in Medicare (or have a valid opt-out affidavit
on file) for their prescriptions to be covered under Medicare Part
D. CMS is delaying enforcement so that it "minimizes the
potential for disrupting beneficiaries' access to needed Part D
medications." The announcement and various CMS guidance
documents regarding the enrollment requirements are available here.
This article is presented for informational purposes only
and is not intended to constitute legal advice.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...